Search
for

    Sort by

    Research 151–180 of 1000+

    1. The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men The Journal of Steroid Biochemistry and Molecular Biology · 2012 · 8 citations
    2. Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study Clinical Cosmetic and Investigational Dermatology · 2024 · 2 citations
    3. The Relationship between Lichen Planus and Carotid Intima Media Thickness. PubMed · 2016 · 2 citations
    4. Occult fungal infection is the underlying pathogenic cause of atherogenesis Medical Hypotheses · 2004 · 2 citations
    5. Frequency of Dyslipidemia in Patients with Lichen Planus: A Comparative Cross-Sectional Study Journal of the Liaquat University of Medical and Health Sciences · 2022
    6. Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial Scientific Journal of Kurdistan University of Medical Sciences · 2022
    7. Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure Endocrinology&Metabolism International Journal · 2016
    8. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review Nutrition Research · 2018 · 11 citations
    9. Syndrome des ovaires polykystiques : Point de vue contemporain Journal of Obstetrics and Gynaecology Canada · 2010 · 2 citations
    10. Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups International Journal of Gynaecology Research · 2025
    11. Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor Springer eBooks · 2016
    12. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society The Journal of Clinical Endocrinology & Metabolism · 2010 · 815 citations
    13. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1 Endocrine Practice · 2015 · 343 citations
    14. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocrine Reviews · 2008 · 343 citations
    15. Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence The Journal of Sexual Medicine · 2014 · 204 citations
    16. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin European journal of endocrinology · 2013 · 116 citations
    17. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic Human Reproduction · 2010 · 111 citations
    18. Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study Journal of The American Academy of Dermatology · 2010 · 110 citations
    19. The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide Journal of Translational Medicine · 2019 · 97 citations
    20. Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential International Journal of Molecular Sciences · 2019 · 75 citations
    21. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS Human Reproduction · 2006 · 71 citations
    22. The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders ˜The œAmerican journal of medicine · 1995 · 57 citations
    23. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome JAMA Dermatology · 2015 · 53 citations
    24. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. The Journal of Clinical Endocrinology and Metabolism · 1996 · 49 citations
    25. Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis International Journal of Cardiology · 2014 · 48 citations
    26. Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference? Nutrition in Clinical Practice · 2008 · 48 citations
    27. <i>Acorus calamus</i>: a bio-reserve of medicinal values 2018 · 45 citations
    28. 11 Treatment of hirsutism and acne with cyproterone acetate Clinics in Endocrinology and Metabolism · 1986 · 43 citations
    29. Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs Frontiers in Endocrinology · 2024 · 42 citations
    30. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction · 2004 · 38 citations